2.31k likes | 2.36k Views
MALARIA. What is Malaria?. You know it. Well done. And for those who think they know little about malaria, follow us for next 35 minutes and go through your book at home. MALARIA. THE PARASITE. Plasmodium falciparum Plasmodium vivax Plasmodium ovale Tropical Africa
E N D
What is Malaria? • You know it. Well done. • And for those who think they know little about malaria, follow us for next 35 minutes and go through your book at home.
MALARIA THE PARASITE
Plasmodium falciparum • Plasmodium vivax • Plasmodium ovale • Tropical Africa • Plasmodium malariae • Karnataka
MALARIA THE VECTOR
Some species • An. culicifacies • An. fluviatilis • An. stephensi • An. minimus • An. philippinensis • An. sundaicus • An. maculatus
Factors which determine vectorial importance of mosquitoes • DENSITY • Critical density- below which effective transmission cannot be maintained in a community • An. culicifacies- high density • An. fluviatilis- low density • LIFE SPAN
CHOICE OF HOST • Anthrophilic species like An. fluviatilisare better vectors of malaria than zoophilic species • RESTING HABITS • Endophily • Exophily • BREEDING HABITS • TIME OF BITING • RESISTANCE TO INSECTICIDES
MALARIA THE DISEASE
Reservoir of infection • Human reservoir • Harbors the sexual forms (gametocytes) of the parasite • P. malariae • Chimpanzees in tropical Africa
A patient can be a carrier of several plasmodia species at the same time • Children are more likely to be gametocyte carriers than adults. The child is thus epidemiologically a better reservoir than the adult.
Conditions that must be met before a person can serve as a reservoir • Both male and female gametocytes are present in blood • Gametocytes are mature • Gametocytes are viable • Gametocytes are present in sufficient density to infect mosquitoes (at least 12/cumm of blood)
Period of communicability • As long as mature, viable gametocytes exist in circulating blood in sufficient density
Mode of transmission • Vector transmission • Direct transmission • Congenital malaria
Incubation period • Falciparum • 12 (9-14) • Vivax • 14 (8-17) • Ovale • 17 (16-18) • Malariae • 28 (18-40)
Clinical features • Signs and symptoms • Complications • Cerebral malaria • ARF • Liver damage • GI symptoms • Dehydration • Collapse • Anemia • Blackwater fever
Anemia • Splenomegaly • Enlargement of liver • Herpes • Renal complications
MALARIA GLOBAL SCENARIO
Every minute 2 people die of malaria. By the time we will finish this lecture malaria would have killed180 more people.
MALARIA SOUTH-EAST ASIA REGION
MALARIA PREVENTION & control
A. Malaria Vector Control • Integrated Vector Management (IVM) • Indoor Residual Spraying (IRS) • Insecticide Treated Nets (ITNs) • Other methods • Larviciding • Environmental management approaches to vector control • Personal protection measures (includes ITNs) • Fogging or area spraying Integrated vector management (IVM) is a rational decision-making processfor the optimal use of resourcesin the management of vector populations, so as to reduce or interrupt transmission of vector-borne diseases.
INSECTICIDES Organo-Chlorines DDT Organo-Phosphates Malathion,Abate, Fenthion, Chlorpyrifos Carbamates Propoxur, Carbaryl Synthetic pyrethroids Tetramethrin, Resmethrin, Allethrin
B. Diagnosis • Direct Microscopy • RDTs (Rapid diagnostic tests)
Histidine-rich protein-2 (HRP2) • Parasite-specific lactate dehydrogenase (pLDH)
C. Treatment Chloroquine25 mg/Kg over 3days PLUS Primaquine0.25 mg/kg BW daily for 14 days CQ Sensitive Vivax ACT PLUS Primaquine0.25 mg/kg BW daily for 14 days CQ Resistant ACT PLUS Primaquine0.75 mg/kg BW single dose Falciparum Severe Malaria ParenteralArtemesinin derivatives/Quinine Followed by full course of ACT
Plasmodium vivax cases • Day 0: T. Chl 10 mg/kg BW (600 mg adult dose) • Day 1: T. Chl 10 mg/kg BW (600 mg adult dose) • Day 2: T. Chl 5 mg/kg BW (300 mg adult dose) • PLUS • T. Primaquin 0.25 mg/kg BW daily for 14 days
ACT (Artesunate Combination Therapy) • T. Artesunate 4mg/kg BW daily X 3days • PLUS • T. Sulphadoxine 25 mg/kg BW and T. Pyrimethamin 1.25 mg/kg BW on the first day • Resistance to Chloroquine and ACT • Oral Quinine 10 mg/kg BW and T. Doxycycline 100 mg daily for 3 days THEREAFTER T. Primaquin 0.75 mg/kg BW single dose
Artesunate 2.4 mg/Kg BW IV or IM at 0, 12 & 24 hrs, then daily • Artemether 3.2 mg/Kg BW at 0, then 1.6 mg.Kg BW per day • Quinine 20 mg salt/Kg BW at 0 (IV infusion), then 10 mg/Kg BW every 8 hrs
Pre-erythrocytic vaccines • Blood-stage vaccines • Transmission-blocking vaccines • Pfs25 • Cocktail vaccines • SPf66
F. Chemoprophylaxis • Travelers from non-endemic areas • Soldiers serving in highly endemic areas • Migrant labourers • Should be complemented by personal protection and environmental measures • Intermittent preventive treatment in pregnancy
For short-term prophylaxis (< 6 weeks) • Doxycycline 100 mg X OD in adults or 1.5 mg/kg BW for children >8 years old. • Started 2 days before travel and continued for 4 weeks after leaving the malarious area. • Contraindicated in pregnant females and children <8 years. • For long-term prophylaxis (>6 weeks) • Mefloquine 5 mg/kg BW (upto 250 mg) weekly • Started 2 weeks before travel and continued till 4 weeks of leaving the malarious area. • Contraindicated in cases with H/O convulsions, neuropsychiatric problems and cardiac conditions.